Scientists will be able to detect cancer earlier from blood samples after advances were made in detecting microRNA molecules using gold-plated nanoparticles.
UNSW researchers have discovered a new way to detect ultralow levels of microRNA in a blood sample which could make diagnosis of cancer and other illnesses quicker and more efficient.
The research team used nanoparticles to latch on to the targeted microRNAs (miRNAs) which enabled them to be easily extracted. One of the main benefits was that it was effective even when the miRNA was in minuscule amounts in the blood sample. Previously, a much larger sample was needed to extract similar amounts.
MicroRNAs are short RNA molecules that target some messenger RNAs (genetic material used to synthesise proteins) to prevent them from coding for a specific protein. Impaired miRNA activity has been linked with the formation of cancerous tumours as well as metastasis, the spread of cancer to other parts of the body.
Scientia Professor Justin Gooding said the nanoparticles are, in effect, dispersible electrodes. When circulated through the blood they capture the miRNA before a magnet is used to recapture the nanoparticles with the newly attached microRNA.
“Now we get more of the microRNA because the dispersible electrodes capture nearly everything in the sample,” Professor Gooding said.
“Because the capture is so effective, we get higher sensitivities and can detect much lower limits.
“And since we bring them back to the electrode under a magnet, our response time is much faster.”
One of the advantages of being quicker is that it will cost less.
“It could be orders of magnitude cheaper. Our method takes 30 minutes compared with almost 12 hours for quantitative polymerase chain reaction,” Professor Gooding said.
Key to the new technology is not just the ability to detect lower concentrations of miRNA but the ability to detect a broad range of concentrations.
“This is really important to determine whether the levels of different microRNAs have increased or decreased,” Professor Gooding said.
“We can do this very quickly compared with the gold-standard nucleic acid amplification methods. And we can do it in unprocessed blood.
“What this means is the technology has the potential to determine the levels of microRNA just from a finger prick test.”
Professor Gooding said he would expect the technology to be available within three years, pending regulatory approvals.
The new diagnostic technique follows on the heels of a similar advance made by another UNSW research team exploring cancer detection in the blood.
In that study, published in Nature Communications, a team of medical researchers led by Professor Chris Heeschen developed a new way to detect early-stage cancer tumour cells in the blood using a malaria protein. This method, which targeted individual cancer cells found in a blood sample, also used a magnet to retrieve all the targeted cancer cells.
Professor Gooding believes the two methods, while working on very different scales, would be very complementary as tools to diagnose cancer.
“The malaria protein technology works by detecting cancer cells, rare cells in particular. These are found in the blood also and so are also compatible with the liquid biopsy concept,” he said.
“We are detecting small molecules found in the blood which could also identify the type of cancer, while they are looking for rare cells that are responsible for the spread of cancer. The two technologies could work very well together.”
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- Prostate cancer screening is better than originally thought, especially for Black men, study sayson May 17, 2022 at 11:56 am
B: A LOT OF IT IS WITH THE SCREENING. WE CAN TAKE A BLOOD TEST AND GET A NUMBER TO FIGURE OUT WHAT YOUR RISK FACTORS WOULD BE AND WHAT COSME NEXT FOR DIAGNOSING THE CANCER IF YOU HAVE IT. SHELDON: ...
- As Red Cross Moves to Pricey Blood Treatment Method, Hospitals Call for More Choiceon May 17, 2022 at 10:33 am
The nation's largest supplier of platelets is moving to a method it says is easier for hospitals, but one that sharply raises costs, leading some centers to demand more options.
- Cancer patients face higher risks of drug interactionson May 17, 2022 at 8:23 am
Here's a scenario so common that it applies to nearly 92% of older adults with cancer: An individual comes in for treatment and reports taking several medications that might include a drug for high ...
- Mother with ‘more than 100 tumours’ in her body reveals the everyday symptom that was a sign of stage 4 canceron May 17, 2022 at 6:25 am
Birmingham catering assistant Amie Walton desperately wants “just a little” bit more time with her beloved children Harry, eight, and Mia, six ...
- Illumina's Grail to offer cancer detection blood test to patients in Utahon May 17, 2022 at 6:04 am
Illumina's (ILMN) subsidiary Grail said on Tuesday it will offer its multi-cancer early detection blood test, Galleri, to eligible patients in Utah. The test will also be ...
- Mirvie Raises $60 Million For Blood Test To Predict Pregnancy Complicationson May 17, 2022 at 6:00 am
Cofounders Maneesh Jain and Stephen Quake are applying liquid biopsy, a non-invasive diagnostic technology better known for cancer screening, to pregnancy.
- I Was Told I'm Pregnant. Then I Found Out It's Likely Cancer — And I'm Actually Relieved.on May 17, 2022 at 6:00 am
"With cancer, disease or dysfunction, there is no government intervention or regulation restricting care. ... No one claims cancer cells have a right to thrive." ...
- GRAIL and Intermountain Healthcare Expand Partnership to Offer Galleri® Multi-Cancer Early Detection Blood Test to Eligible Patients in Utahon May 17, 2022 at 5:09 am
NDAQ:ILMN) GRAIL and Intermountain Healthcare Expand Partnership to Offer Galleri® Multi-Cancer Early Detection Blood Test to Eligible Patients in Utah ...
- Study: Benefits of prostate cancer blood test outweigh harmson May 16, 2022 at 8:34 am
The blood test used to detect prostate cancer may be more effective at preventing deaths — particularly among Black men — than previously thought, according to a study in NEJM ...
- The Galleri Test: New blood test to screen 50 types of cancerson May 9, 2022 at 11:21 am
Most often, cancer will shed its specific DNA into your bloodstream. With one blood draw, the Galleri Test can use its DNA sequencing to test whether the various patterns of DNA contain a cancer ...
via Bing News